|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q96G97 |
| Protein name |
Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein) |
| Protein function |
Plays a crucial role in the formation of lipid droplets (LDs) which are storage organelles at the center of lipid and energy homeostasis (PubMed:19278620, PubMed:21533227, PubMed:30293840, PubMed:31708432). In association with LDAF1, defines the |
| PDB |
6DS5
|
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF06775 |
Seipin |
39 → 243 |
Putative adipose-regulatory protein (Seipin) |
Family |
|
| Tissue specificity |
TISSUE SPECIFICITY: Expressed in motor neurons in the spinal cord and cortical neurons in the frontal lobe (at protein level). Highly expressed in brain, testis and adipose tissue. {ECO:0000269|PubMed:11479539, ECO:0000269|PubMed:18458148, ECO:0000269|Pub |
| Sequence |
|
| Sequence length |
398 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Abnormal central motor function |
Likely pathogenic; Pathogenic |
rs137852973 |
RCV001813950 |
| Berardinelli-Seip congenital lipodystrophy |
Pathogenic; Likely pathogenic |
rs587777606, rs786205069, rs587777608, rs786205071, rs137852970, rs137852971, rs758843908, rs137852973, rs137852974, rs137852975, rs749890533, rs766061024, rs1013079991, rs1064797076 |
RCV003311693 RCV003311636 RCV003311638 RCV003311639 RCV003311640 RCV003311642 RCV003311643 RCV003311647 RCV003311648 RCV003311649 RCV003311803 RCV003311802 RCV003311801 RCV003311824 RCV003311850 |
| Breast carcinoma |
Pathogenic |
rs190405606 |
RCV001777125 |
| BSCL2-related disorder |
Likely pathogenic; Pathogenic |
rs137852973, rs749890533 |
RCV004766979 RCV004701455 |
| Charcot-Marie-Tooth disease |
Pathogenic |
rs137852973 |
RCV000789082 |
| Charcot-Marie-Tooth disease type 2 |
Likely pathogenic; Pathogenic |
rs777430457, rs2134690008, rs2134689565, rs1244155207, rs587777606, rs587777608, rs786205071, rs137852971, rs758843908, rs137852973, rs137852975, rs2539155047, rs2539181714, rs2539154728, rs1402657239, rs879254029, rs2539145269, rs749890533, rs1554982914, rs1011200048, rs779154593, rs1945289474, rs1945285043 View all (8 more) |
RCV001379197 RCV001390710 RCV001864691 RCV001970095 RCV000800475 RCV005089168 RCV002512772 RCV003581554 RCV001851654 RCV000547334 RCV000196081 RCV002681753 RCV002846756 RCV003048498 RCV003581939 RCV003582731 RCV003744196 RCV003743517 RCV001387719 RCV000544751 RCV000536990 RCV001047252 RCV001218067 RCV001240096 RCV001232406 |
| Congenital generalized lipodystrophy type 2 |
Pathogenic; Likely pathogenic |
rs587777606, rs1011200048, rs786205069, rs587777608, rs786205071, rs137852970, rs137852971, rs758843908, rs137852974, rs137852975, rs879254029, rs749890533, rs766061024, rs1013079991, rs1057524896, rs1064797076, rs1554983076, rs1565144681, rs747297291, rs1565152616, rs557044760, rs1565142553, rs779154593 View all (8 more) |
RCV000412493 RCV002248981 RCV000004790 RCV000004793 RCV000004794 RCV000004795 RCV000004797 RCV000004798 RCV000004804 RCV000004805 RCV000761469 RCV000412601 RCV000412618 RCV000412607 RCV004796180 RCV000487432 RCV000503732 RCV000754917 RCV000754918 RCV000754916 RCV000754919 RCV000761421 RCV005049743 RCV005049797 |
| Developmental and epileptic encephalopathy |
Likely pathogenic |
rs2539174013 |
RCV003225675 |
| Hereditary spastic paraplegia 17 |
Pathogenic; Likely pathogenic |
rs786205071, rs137852971, rs137852973, rs749890533, rs766061024, rs1011200048, rs779154593 |
RCV002496260 RCV005049316 RCV000004803 RCV002502439 RCV005049541 RCV002284966 RCV005049743 RCV005049797 |
| Lipodystrophy |
Likely pathogenic; Pathogenic |
rs1064797076 |
RCV001836829 |
| Monogenic diabetes |
Likely pathogenic; Pathogenic |
rs1057524896 |
RCV000445443 |
| Neuronopathy, distal hereditary motor, type 5A |
Likely pathogenic; Pathogenic |
rs137852973 |
RCV000755016 |
| Neuronopathy, distal hereditary motor, type 5C |
Pathogenic; Likely pathogenic |
rs786205071, rs137852970, rs137852971, rs137852973, rs749890533, rs766061024, rs1011200048, rs779154593 |
RCV002496260 RCV002298433 RCV005049316 RCV001270681 RCV002502439 RCV005049541 RCV001270682 RCV005049743 RCV005049797 |
| Reduced delayed hypersensitivity |
Pathogenic |
rs190405606 |
RCV001775209 |
| Severe neurodegenerative syndrome with lipodystrophy |
Pathogenic; Likely pathogenic |
rs587777606, rs2539144290, rs587777608, rs786205071, rs137852971, rs758843908, rs749890533, rs766061024, rs1057524896, rs1011200048, rs779154593 |
RCV000133397 RCV002465429 RCV000133399 RCV002496260 RCV005049316 RCV006249352 RCV002502439 RCV005049541 RCV004796180 RCV005049743 RCV001196242 RCV005049797 |
| Symphalangism affecting the proximal phalanx of the 4th finger |
Pathogenic |
rs190405606 |
RCV001775210 |
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| BSCL2-related Developmental and epileptic encephalopathy |
Uncertain significance |
rs1060503382 |
RCV001836825 |
| Congenital generalized lipodystrophy |
Conflicting classifications of pathogenicity |
rs144245125 |
RCV000328674 |
| Hereditary spastic paraplegia |
Uncertain significance; Likely benign; Conflicting classifications of pathogenicity; Benign |
rs778455259, rs144725547, rs370905417, rs145393127, rs1196120956, rs1440384464, rs2134740707, rs145649423, rs6856, rs149466797, rs786205072, rs144245125, rs369806785, rs117862461, rs117597269, rs369732238, rs149907021, rs141377075, rs763884653, rs190842600, rs200631909, rs141657385, rs754683462, rs375554369 View all (9 more) |
RCV001847241 RCV001847239 RCV001848344 RCV001848345 RCV001848346 RCV001848347 RCV001848348 RCV001847675 RCV001847676 RCV001847805 RCV001847581 RCV001847821 RCV001847934 RCV001848085 RCV001848084 RCV001848785 RCV001848815 RCV000515840 RCV000516060 RCV001848974 RCV001848989 RCV001849047 RCV005626194 RCV001847050 |
| Intellectual disability |
Conflicting classifications of pathogenicity |
rs149907021 |
RCV005625614 |
| Isolated systolic hypertension |
Benign |
rs6856 |
RCV002463437 |
| Neurologic Disorders/Seipinopathy |
Conflicting classifications of pathogenicity |
rs144245125 |
RCV000271246 |
| Neutrophilia in presence of infection |
Benign |
rs6856 |
RCV002463437 |
| PPARG-related familial partial lipodystrophy |
Likely benign |
rs1057516190 |
RCV000408866 |
| See cases |
Uncertain significance |
rs2083510633, rs2539144149 |
RCV002252845 RCV003232938 |
| Triangular shaped proximal phalanx of the thumb |
Benign |
rs6856 |
RCV002463437 |
| Young-onset Parkinson disease |
Uncertain significance |
rs140762669 |
RCV005626690 |
|
| Disease Name |
Relationship Type |
References |
| 6q24 Related Transient Neonatal Diabetes Mellitus |
Associate |
35351089 |
| Aphasia |
Associate |
30903322 |
| Brain Diseases |
Associate |
27391332, 29367704, 30447390, 30903322, 31341166, 31369919 |
| Cardiomyopathies |
Associate |
21126715, 27612026 |
| Cardiomyopathy Hypertrophic |
Associate |
19041432, 20616664, 23659685 |
| Charcot Marie Tooth Disease |
Associate |
29336362 |
| Cognition Disorders |
Associate |
30563316 |
| COVID 19 |
Associate |
36510129 |
| Cystic Fibrosis |
Inhibit |
33482299 |
| Daneman Davy Mancer syndrome |
Associate |
16735770 |
| Death |
Stimulate |
12362029, 30296183 |
| Diabetes Mellitus |
Associate |
23659685, 27612026, 30296183, 32792356, 35351089, 38408297 |
| Diabetes Mellitus Type 2 |
Associate |
30563316 |
| Distal Hereditary Motor Neuropathy Type II |
Associate |
17663003 |
| Embolism Fat |
Stimulate |
30296183 |
| Embolism Fat |
Associate |
30901948 |
| Epilepsies Myoclonic |
Associate |
30903322 |
| Epileptic Encephalopathy Early Infantile 3 |
Associate |
31369919 |
| Genetic Diseases Inborn |
Associate |
32792356, 38408297 |
| Glycogen Storage Disease Type IV |
Associate |
32349771 |
| Heart Diseases |
Associate |
19041432 |
| Heart Failure |
Associate |
19041432 |
| Hereditary Myopathy with Early Respiratory Failure |
Associate |
36539320 |
| Heredodegenerative Disorders Nervous System |
Associate |
27391332 |
| Hypertension |
Associate |
19041432 |
| Hypertrophy |
Associate |
29478747 |
| Infantile Epileptic Dyskinetic Encephalopathy |
Associate |
31369919 |
| Infections |
Associate |
35351089 |
| Inflammation |
Associate |
36510129 |
| Intellectual Disability |
Associate |
15181077 |
| Intellectual Disability |
Stimulate |
30296183 |
| Iron Deficiencies |
Associate |
39773523 |
| Lipid Metabolism Disorders |
Associate |
25832430 |
| Lipodystrophy |
Inhibit |
12362029 |
| Lipodystrophy |
Associate |
23659685, 24961962, 30903322, 30940487, 36384728, 38231342, 38408297 |
| Lipodystrophy Congenital Generalized |
Associate |
12362029, 15181077, 16735770, 18211975, 19041432, 20684003, 21062080, 21126715, 23659685, 24961962, 27144933, 27612026, 27868354, 29478747, 30296183, 30864635, 30901948, 30903322, 31770241, 32349771, 34033296, 34645804, 35351089, 35735786, 36384728 View all (10 more) |
| Mental Retardation Autosomal Recessive 1 |
Stimulate |
12362029 |
| Mental Retardation Autosomal Recessive 1 |
Associate |
21126715 |
| Mobility Limitation |
Associate |
29478747 |
| Motor Neuron Disease |
Associate |
39773523 |
| Muscular Atrophy Spinal |
Associate |
19396477 |
| Muscular Diseases |
Associate |
27144933, 36539320 |
| Muscular dystrophy congenital with central nervous system involvement |
Associate |
30903322 |
| Nerve Degeneration |
Associate |
19396477 |
| Neurologic Manifestations |
Associate |
30901948, 30903322 |
| Neuronopathy Distal Hereditary Motor Type V |
Associate |
16574104, 17663003 |
| Ovarian Neoplasms |
Associate |
31655274 |
| Parkinson Disease |
Associate |
40594234 |
| pediatric multisystem inflammatory disease COVID 19 related |
Associate |
36510129 |
| Peripheral Nervous System Diseases |
Associate |
17663003, 25832430 |
| Polyneuropathies |
Associate |
30563316 |
| Spastic paraplegia 17 |
Associate |
11389484, 16574104, 17663003 |
| Spastic Paraplegia Hereditary |
Associate |
17663003 |
| Thyroid Cancer Papillary |
Associate |
30864635 |
|